Peter Palese
Affiliations: | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Microbiology BiologyGoogle:
"Peter Palese"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
González-Domínguez I, Abdeljawad A, Lai TY, et al. (2025) Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models. Frontiers in Immunology. 16: 1524477 |
Peixoto de Miranda ÉJF, Calado RT, Boulos FC, et al. (2025) Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil. Vaccine. 52: 126680 |
Slamanig S, Lemus N, Lai TY, et al. (2024) A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge. Vaccine. 45: 126586 |
González-Domínguez I, Puente-Massaguer E, Abdeljawad A, et al. (2024) Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach. Npj Vaccines. 9: 222 |
Rathnasinghe R, Chang LA, Pearl R, et al. (2024) Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity. Npj Vaccines. 9: 169 |
Torres-Flores A, Ontiveros-Padilla LA, Madera-Sandoval RL, et al. (2024) Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals. Frontiers in Immunology. 15: 1394114 |
Slamanig S, González-Domínguez I, Chang LA, et al. (2024) Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice. Ebiomedicine. 105: 105185 |
Bliss CM, Nachbagauer R, Mariottini C, et al. (2024) A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein. Ebiomedicine. 104: 105153 |
Martínez JL, Lemus N, Lai TY, et al. (2024) The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex. Vaccine |
Van Reeth K, Parys A, Gracia JCM, et al. (2023) Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine. Nature Communications. 14: 7745 |